The BMNPs were Fe3O4-anti-AFP (MF-AFP-0060, MagQu Co. Ltd., New Taipei City, Taiwan), and the biotarget was AFP, which is a biomarker for diagnosing HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.